Ardian-backed Ionisos buys Scandinavian Clinics Estonia
Ionisos, backed by buyout house Ardian, has acquired a majority stake in Baltic gamma ray sterilisation specialist Scandinavian Clinics Estonia.
Ardian's expansion team led the transaction, which is the fourth external growth operation carried out by Ionisos since the GP acquired a majority stake in July 2016.
The deal was self-financed and no additional equity was used, the company confirmed with unquote".
With the new acquisition, the company intends to develop through organic growth and further acquisitions.
Ardian acquired its stake in Ionisos via its Expansion Fund IV, which held a €1bn final close in June 2016.
Ardian was initially attracted to the company by its potential to expand geographically to the north and east of Europe, serving Finland, Sweden, Norway and the Baltic countries, a company spokesperson told unquote".
Company
Founded in 2007 and based in Harju County in Estonia, near Tallinn, Scandinavian Clinics Estonia provides gamma-ray sterilisation treatment in the Baltic states. The company states it has the capacity to also meet the sterilisation needs of northern Europe, specifically in Norway, Sweden, Finland and Poland.
Following the acquisition, the group will be renamed Ionisos Baltics.
People
Ardian – François Jerphagnon (head of expansion team).
Ionisos – Christoph Herkens (managing director).
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Czech Republic-headquartered family office is targeting DACH and CEE region deals
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Ex-Rocket Internet leader Bettina Curtze joins Swiss VC firm as partner and CFO
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Estonia-registered VC could bolster LP base with fresh capital from funds-of-funds or pension funds









